Vestibular Function Tests ID Vestibular Migraine Versus Meniere Disease
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
FRIDAY, July 7, 2023 -- Vestibular symptoms and results from vestibular function tests may differentiate between vestibular migraine (VM) and Meniere disease (MD), according to a study published in the July/August issue of the Brazilian Journal of Otorhinolaryngology.
Yuexia Wu, from the First Hospital of Hebei Medical University in Shijiazhuang, China, and colleagues compared the clinical characteristics and vestibular function test results between VM (71 patients) and MD patients (31 patients).
The researchers found that most VM patients (64.0 percent) experienced spontaneous internal vertigo, while most MD patients (66.7 percent) experienced spontaneous external vertigo. More severe vestibular symptoms and autonomic responses were seen in MD patients versus VM patients during attacks. In VM patients, the nystagmus intensity of caloric test (CT)-induced was greater than in MD patients and more VM patients had CT intolerance and central positional nystagmus versus MD patients. More MD patients had CT(+) and video head impulse test (vHIT) saccades wave versus VM patients. Furthermore, in MD patients, the nonelicitation rate of cervical vestibular evoked myogenic potential (VEMP) was higher and the ocular VEMP amplitudes were lower versus VM patients.
"The diverse nature of vestibular symptoms (especially internal vertigo), history of motion sickness and CT intolerance may provide clues to the diagnosis of VM, whereas spontaneous external vertigo, CT(+) with vHIT(−), and the presence of saccades may provide clues to the diagnosis of MD," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted July 2023
Read this next
Targeted Diagnostic Botox Injections Can Identify Trigger Sites for Migraine
THURSDAY, May 9, 2024 -- Diagnostic targeted Botox injections have high positive predictive value for migraine trigger site localization, according to a study published in the May...
Study Compares Vestibular Endolymphatic Hydrops Grading Methods in Meniere Disease
TUESDAY, May 7, 2024 -- In a study published online April 17 in the European Archives of Oto-Rhino-Laryngology, different grading methods for vestibular endolymphatic hydrops (EH)...
Multifrequency Tympanometry Could Aid Diagnosis of Meniere Disease
MONDAY, May 6, 2024 -- Multifrequency tympanometry (MFT) could aid the diagnosis of Meniere disease (MD), according to a review published online March 4 in the Journal of...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.